Abstract
In this chapter, we deal with vascular accesses in cancer patients, complications associated with those devices, and nursery care. Long-term venous catheters, especially tunneled catheters, are essential for cancer treatment, with wide applicability in various stages of treatment. In addition to enabling the infusion of drugs and blood products, they also allow the collection of blood samples for laboratory analysis, the monitoring of hemodynamic parameters, parenteral nutrition, and the performance of essential procedures for maintaining life, such as hemodialysis sessions.
The indications and types of catheters are discussed, taking into account the time of use, the compatibility of the drug with the peripheral venous system, and the risk of infection. Most frequent complications and how to avoid them are also a subject in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Harvey W. Excercitatio Anatomica de Moto Cordis et Sanguinus in Animalbus. Franco-furti:Guilielmi Fitzeri; p. 1628.
Zerati AE, Wolosker N, de Luccia N, Puech-Leão P. Totally implantable venous catheters: history, implantation technique and complications. J Vasc Bras. 2017;16(2):128–39.
Barsoum N, Kleeman C. Now and then, the history of parenteral fluid administration. Am J Nephrol. 2002;22:284–9.
Blundell J. Successful case of transfusion. Lancet. 1829;I:431–2. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973;136:602–6.
Zimmermann B. Intravenous tubing for parenteral therapy. Science. 1945;101:567–8.
Aubaniac R. L’injection intraveineuse sous-claviculaire: advantages et technique. Presse Med. 1952;60:1456.
Seldinger SI. Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol. 1953;39:368–76.
Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973;136:602–6.
Hickman RO, Buckner CK, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet. 1979;148:871–5.
Belin RP, Koster JK Jr, Bryant LJ, Griffen WO Jr. Implantable subcutaneous feeding chamber for noncontinuous central venous alimentation. Surg Gynecol Obstet. 1972;134(3):491–3.
Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982;92:706–12.
Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proc. 2006;81:1159–71.
Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin. 2008;58(6):323–46.
Biffi R, de Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer. 2001;92:1204–12.
Zottele Bomfim GA, Wolosker N, Yazbek G, Bernardi CV, Valentim LA, De Castro TM, Pignataro BS, Benitti DA, Nishinari K. Comparative study of valved and nonvalved fully implantable catheters inserted via ultrasound-guided puncture for chemotherapy. Ann Vasc Surg. 2014;28:351–7.
Galloway S, Bodenham A. Long-term central venous access. Br J Anaesth. 2004;92:722–34.
Wolosker N, Yazbek G, Munia MA, Zerati AE, Langer M, Nishinari K. Totally implantable femoral vein catheters in cancer patients. Eur J Surg Oncol. 2004;30(7):771–5.
Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg. 2004;188(6):722–7.
Zerati AE, Wolosker N, da Motta-Leal-Filho JM, Nabuco PH, Puech-Leão P. Totally implantable venous catheters: insertion via internal jugular vein with pocket implantation in the arm is an alternative for diseased thoracic walls. J Vasc Access. 2012;13(1):71–4.
Freire MP, Pierrotti LC, Zerati AE, Araújo PH, Motta-Leal-Filho JM, Duarte LP, Ibrahim KY, Souza AA, Diz MP, Pereira J, Hoff PM, Abdala E. Infection related to implantable central venous access devices in cancer patients: epidemiology and risk factors. Infect Control Hosp Epidemiol. 2013;34(7):671–7.
Johansson E, Hammarskjold F, Lundberg D, Arnlind MH. Advantages and disadvantages of peripherally inserted central venous catheters (PICC) compared to other central venous lines: a systematic review of the literature. Acta Oncol. 2013;52:886–92.
Chopra V, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382:311–25.
Pittiruti M, Giancarlo MS. Manual GAVeCeLT de PICC e catheter Midline. Italia: Costanza Smeraldi; 2016. p. 1–200.
Kalil M, et al. Peripherally inserted central venous catheters : alternative or first choice vascular access? J Vasc Bras. 2017;16(2):104–12.
Todd J. Peripherally inserted central catheters and their use in IV therapy. Br J Nurs. 1999;8(3):140–8.
Dawson RB. PICC Zone Insertion MethodTM (ZIMTM): a systematic approach to determine the ideal insertion site for PICCS in the upper arm. J Assoc Vasc Access. 2011;16(3):156–65.
Chopra V, et al. The Michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA Appropriateness Method. Ann Intern Med. 2015;163(6):S1–S39.
Bonassa EMA, Gato MIR. Terapêutica Oncológica para Enfermeiros e Farmacêuticos. 4a edição, 2012.
Moreau NL. Vessel health and preservation: the right approach for vascular access. Cham: Springer; 2019. (eBook). https://doi.org/10.1007/978-3-030-03149-7.
Oliveira DAL, Fontes RDA, Silva MB. Cuidados de enfermagem ao paciente oncológico portador de cateter totalmente implantado. Vittalle. 2019;31(1):52–60.
VasquesI CI, dos ReisII PED, de Carvalho EC. Manejo do cateter central totalmente implantado em pacientes oncológicos: revisão integrativa. Acta Paul Enferm. 2009;22(5)
Vasques CI, dos Reis PED. Emília Campos de Carvalho Manejo do cateter central totalmente implantado em pacientes oncológicos: revisão integrativa. Acta Paul Enferm. 2009;22:5, São Paulo.
Gorski L, Hadaway L, Hagle M, McGoldrick M, Orr M, Doellman D. Infusion therapy: standards of practice (supplement 1). J Infus Nurs. 2016;39(1S):S1–S159.
Da Silva GA, Priebe S, Dias FN. Benefits of establishing an intravenous team and the standardization of peripheral intravenous catheters. J Infus Nurs. 2010;33(3):156–8.
Sharma SK, Mudgal SK, Gaur R, Sharma R, Sharma M, Thakur K. Heparin flush vs. normal saline flush to maintain the patency of central venous catheter among adult patients: a systematic review and meta-analysis. J Family Med Prim Care. 2019;8(9):2779–92. https://doi.org/10.4103/jfmpc.jfmpc_669_19.
Pai A, Ferrajoli A, Cheng L, Huynh T, Rodriguez MA. Comparison of normal saline versus heparin flush solutions for maintaining patency of central venous catheter in cancer patients. J Clin Oncol. 2019;
Philipponnet C, Aniort J, Pereira B, Azarnouch K, Hadj-Abdelkader M, Chabrot P, Heng AE, Souweine B. Systematic review of atrial vascular access for dialysis catheter. Kidney Int Rep. 2020;5:1000–6. https://doi.org/10.1016/j.ekir.2020.04.006.
Quintilano A, Praxede MRG. Effectiveness, safety and cost reduction of long-term tunneled central venous catheter insertion in outpatients performed by an interventional nephrologist. J Bras Nefrol. 42(1):53–8.
Beigi AA, Sharifi A, Gaheri H, Abdollahi S, Esfahani MA. Placement of long-term hemodialysis catheter (permcath) in patients with end-stage renal disease through external jugular vein. Adv Biomed Res. 2014;3(252) https://doi.org/10.4103/2277-9175.146381.
Bander SJ, Yuo TH. Central catheters for acute and chronic hemodialysis access and their management. May 20, 2020. Disponível Em: https://www.uptodate.com/contents/central-catheters-for-acute-and-chronic hemodialysis-access-and-their-management
Vescia S, Baumgärtner AK, Jacobs VR, et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol. 2008;19:9–15.
Maffei FHA, et al. Acessos vasculares para hemodiálise, doenças vasculares periféricas, vol. 2. 4th ed. Rio de Janeiro: Guanabara Koogan; 2008. p. 1936–48.
Braga LM, Salgueiro-Oliveira AS, Henriques Maria AP, Arreguy-Sena C, Albergaria Virginia Mirian Pianetti VM, Parreira PMSD. Cateterismo venoso periférico: compreensão e avaliação das práticas de enfermagem. Texto contexto – enferm. [Internet]. 2019. https://doi.org/10.1590/1980-265x-tce-2018-0018.
Bibliography
Chittoodan S, Breen D, O'Donnell BD, Iohom G. Long versus short axis ultrasound guided approach for internal jugular vein cannulation: a prospective randomised controlled trial. Med Ultrason. 2011;13(1):21–5.
Tammam TF, El-Shafey EM, Tammam HF. Ultrasound-guided internal jugular vein access: comparison between short axis and long axis techniques. Saudi J Kidney Dis Transpl. 2013;24(4):707–13.
Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, Lamote J, De Greve J, Van Camp B, Lacor P. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer. 2005;13(5):325–31.
Ballard DH, Samra NS, Gifford KM, Roller R, Wolfe BM, Owings JT. Distance of the internal central venous catheter tip from the right atrium is positively correlated with central venous thrombosis. Emerg Radiol. 2016;23(3):269–73.
Akl EA, Ramly EP, Kahale LA, et al. Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev. 2014;10:Cd006468.
Lavau-Denes S, Lacroix P, Maubon A, et al. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study. Cancer Chemother Pharmacol. 2013;72:65–73.
Schiffer CA, Mangu PB, Wade JC, et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31:1357–70.
Carrier M, Lazo-Langner A, Shivakumar S, et al. Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations. Curr Oncol. 2015;22:49–59.
Bertoglio S, Solari N, Meszaros P, Vassallo F, Bonvento M, Pastorino S, Bruzzi P. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nurs. 2012;35(4):E35–42.
Goossens GA, Jérôme M, Janssens C, Peetermans WE, Fieuws S, Moons P, Verschakelen J, Peerlinck K, Jacquemin M, Stas M. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Ann Oncol. 2013;24(7):1892–9.
Brito ARO, Nishinari K, Saad PF, Saad KR, Pereira MAT, Emídio SCD, Yazbek G, Bomfim GAZ, Cavalcante RN, Krutman M, Teivelis MP, Pignataro BS, Fonseca IYI, Centofanti G, Soares BLF. Comparison between saline solution containing heparin versus saline solution in the lock of totally implantable catheters. Ann Vasc Surg. 2018;47:85–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Editors Comments
Editors Comments
1.1 Echo-Guided Venous Access
Adequate venous access is essential for many patients, especially those admitted to hospitals. The choice of the best access route and the type of catheter are mainly related to the type of substance to be infused, the duration of therapy, and the existence of an adequate peripheral venous network.
Venous access should preferably be obtained through puncture rather than dissection, as it generates less tissue manipulation and lower morbidity rates.
Except for puncture of visible superficial veins and adequate caliber, the accesses must be eco-guided. In addition to the objectives mentioned, one of the applications of ultrasound is to verify the correct direction of the guidewire’s progression, especially in procedures performed at the bedside. As an example, when performing a puncture of the axillary/subclavian vein and with the transducer at the base of the neck at the height of the sternoclavicular junction, it is possible to quickly identify whether the guidewire traveled the wrong path to the ipsilateral internal jugular or had the appropriate path for the ipsilateral innominate venous trunk. If the guidewire has progressed to the internal jugular and with visualization concomitant with ultrasound, the guidewire is initially pulled until its “J” end exits the jugular. The “J” is rotated in the central direction, followed by compression of the transducer with one hand and concomitant progression of the guidewire with the other hand to direct the extremity to the innominate vein. Similarly, it is possible to check the internal or jugular access to the cranial or caudal direction of the guidewire and eventual repositioning.
There are two techniques for visualizing the needle: in-plane or out-of-plane. In the in-plane technique, there is a perfect alignment between the needle and the ultrasound beam during its entire path, which is visualized entirely from its entry into the skin until it reaches the target vessel. In the out-of-plane technique, there is no alignment, just an intersection of the ultrasound beam with the needle, so during the progression of the needle, there is no visualization of it. Visualization of its extremity occurs only when this crossing occurs in the center of the target vessel.
There is no superiority of one technique over another concerning venous access [44, 45].
There are two ways of visualizing the vessel: transverse axis (transducer perpendicular to the vascular bundle) or longitudinal axis (transducer parallel to the bundle).
The echo-guided puncture technique is a combination of the needle view and the vessel view. The best combination choice depends on the type of catheter, anatomical location of the target vessel, and professional experience: as an example, the in-plane puncture of the internal jugular on the longitudinal axis. The only advantage is the almost zero possibility of pneumothorax, as it is an extremely cranial puncture. For short-term catheters, there is a clear disadvantage of the discomfort caused by the catheter externalized far above the neck’s base, and for long-term catheters, the curvature necessary to perform the subcutaneous course is inadequate. Another example is the in-plane puncture of the axillary vein. There is the advantage of comfort in the exterior of the catheter for short-term catheters, but for long-term catheters, there is the disadvantage of curvature.
1.2 Positioning the Catheter Tip
Some imaging methods must be performed concomitantly or immediately after obtaining central venous access for proper positioning of its extremity, the most used being: fluoroscopy, intra-cavity electrocardiogram, and radiography.
The central catheters’ tip must be located in the cavoatrial junction or the right atrium [46, 47], especially in long-term accesses. Significant complications such as device dysfunction and deep venous thrombosis are correlated with poor positioning of the extremity (innominate vein or proximal superior vena cava), being attributed to factors such as the diameter of the vessel/catheter, blood flow speed, and the caustic/hypertonic nature of the solutions (chemotherapy, parenteral nutrition).
1.3 Prophylactic Anticoagulation
It is known that patients with malignant neoplasia have higher rates of thromboembolic events, with the presence of a central venous catheter among the various factors that cause it.
Chemoprophylaxis in these patients with catheters is controversial as to the results, type of anticoagulant (oral or parenteral), dose, and duration. Some studies show a decrease in the number of symptomatic and asymptomatic events [48, 49], others show no advantage, and routine use is not recommended [50, 51].
1.4 Maintenance of Ports
At the end of the use of all central venous catheters, a flush with saline solution is performed, followed by filling with a solution (lock) until further handling, aiming to avoid the deposit of crystals and blood in the lumen leading to dysfunction and/or occlusion.
In ports, heparin lock is classically used between chemotherapy sessions, however, with varying dilutions and time intervals. The use of heparin is based on the fact that it is an anticoagulant substance; therefore, it would minimize the mentioned complications.
Few studies compare maintenance with a heparin lock or saline solution, none of them showing the advantage of using heparin.
A retrospective study comparing occlusion rates with heparin lock (50 IU/mL) versus saline solution showed no difference [52].
A randomized study comparing the reflux dysfunction indices between heparin lock (100 IU/mL) versus saline solution showed no difference [53].
Another retrospective study comparing the reflux dysfunction rates, flow dysfunction, and occlusion between heparin lock (100 IU/mL) versus saline solution also showed no difference [54].
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Saes, G.F., Zerati, A.E., Wolosker, M.B., Barbosa, J.A.S., do Campo Silva, T.C. (2022). Vascular Access. In: Zerati, A.E., Nishinari, K., Wolosker, N. (eds) Vascular Surgery in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-97687-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-97687-3_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-97686-6
Online ISBN: 978-3-030-97687-3
eBook Packages: MedicineMedicine (R0)